Microbot Medical Inc. (MBOT) vs Tenax Therapeutics, Inc. (TENX)

A side-by-side comparison of Microbot Medical Inc. and Tenax Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — MBOT vs TENX

growth of $100 · dividends reinvested · last 10y
MBOT -99.2% (-38.5%/yr)TENX -100.0% (-64.6%/yr)MBOT compounded faster over this window
Log scale — wide-divergence pair
0001101001kStart $10020182020202220242026$1$0
MBOT TENX

MBOT vs TENX: by the numbers

  • •TENX is the larger company ($51M vs $49M market cap).
  • •Both run net losses; TENX's is the smaller (0.00% vs -4722.25% net margin).

Metrics side by side

Valuation

MetricMBOTTENX
P/S ratio142.90N/A
P/B ratio0.720.45

Profitability

MetricMBOTTENX
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin-4722.25%0.00%
ROE-23.70%-57.10%
ROIC-26.51%-60.40%

Growth (annualized)

MetricMBOTTENX
Total return CAGR (5Y)-31.63%-76.80%

Frequently asked

How have MBOT and TENX total returns compared?
Over the past 10 years, MBOT delivered -39.57% and TENX delivered -64.85% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.